The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer  by Liu, Honggen et al.
at SciVerse ScienceDirect
International Journal of Surgery 11 (2013) 419e424
ORIGINAL RESEARCHContents lists availableInternational Journal of Surgery
journal homepage: www.thei js .comOriginal researchThe RML of lymph node metastasis was superior to the LODDS
for evaluating the prognosis of gastric cancer
Honggen Liu, Jingyu Deng, Rupeng Zhang, Xishan Hao, Xuguan Jiao, Han Liang*
Department of Gastrointestinal Oncology, Key Lab of Cancer Treatment and Prevention, Tianjin Cancer Hospital, Tianjin Medical University, Tianjin, Chinaa r t i c l e i n f o
Article history:
Received 3 January 2013
Received in revised form
11 March 2013
Accepted 18 March 2013
Available online 27 March 2013
Keywords:
Stomach
Neoplasm
Ratio between metastatic and examined
lymph nodes
Negative lymph nodes
LODDS* Corresponding author.
E-mail address: tjlianghan@sohu.com (H. Liang).
1743-9191/$ e see front matter  2013 Surgical Asso
http://dx.doi.org/10.1016/j.ijsu.2013.03.009a b s t r a c t
Objective: The aim of the study was to investigate the most appropriate system for categorization of
metastatic lymph nodes among N staging (according to the 7th edition UICC/AJCC TNM Classiﬁcation for
Gastric Cancer), ratio between metastatic and examined lymph nodes (RML) staging, negative lymph
nodes (NLN) staging and log odds of positive lymph nodes (LODDS) staging for evaluation the overall
survival (OS) of gastric cancer.
Methods: We reviewed clinicopathological data of 372 gastric cancer patients who underwent radical
gastrectomy plus extended lymphadenectomy with the purpose of evaluating the differences in the OS
according to different categories of metastatic lymph nodes.
Results: Univariate and multivariate analysis of data signiﬁcantly identiﬁed the degree of differentiation
(HR ¼ 1.404, p ¼ 0.015), T staging (according to the 7th edition UICC/AJCC TNM Classiﬁcation for Gastric
Cancer) (HR ¼ 1.568, p ¼ 0.024) and the RML staging (HR ¼ 1.479, p ¼ 0.030) as independent predictors
of the OS. However, RML staging was identiﬁed as the most appropriate for evaluating the OS of gastric
cancer patients following radical gastrectomy plus extended lymphadenectomy rather than N staging,
NLN staging and LODDS staging by using the caseecontrol matched analysis. With the further stratiﬁed
analysis, we demonstrated that RML staging had the best prognostic homogeneity than LODDS staging,
NLN staging or N staging.
Conclusions: RML staging was the best system for prediction the OS of the gastric cancer patients
following radical gastrectomy plus extended lymphadenectomy, rather than LODDS staging, NLN staging
or N staging.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Gastric cancer was the second leading cause of cancer related
death in the world.1 Lymph node metastasis was one of the most
important prognostic factors in gastric cancer.2 It was demon-
strated that the staging which was based on the location of positive
lymph nodes was inferior to the number-based N staging in the
prognostic prediction of gastric cancer.3 Union for International
Cancer Control (UICC)/American Joint Committee on Cancer (AJCC)
TNM staging system was widely used to evaluate gastric cancer
worldwide.4 Although N staging from UICC/AJCC TNM was a
convenient and reproducible method for precise staging, it usually
had stage migration, which misguided further treatment and
prognostic prediction. To avoid above problems, ratio between
metastatic and examined lymph nodes (RML) was proposed. Manyciates Ltd. Published by Elsevier Ltstudies demonstrated that the RML staging was superior to the
number-based N staging,5e7 because of less inﬂuence by the total
number of retrieved lymph nodes (TLN). But some authors held
different viewpoints.8 Recently, newer method for categorization of
metastatic lymph nodes was developed to overcome the deﬁcits of
N staging and RML staging systems. Deng et al.9,10 proposed that
the number of negative lymph nodes (NLN) was signiﬁcantly
associated with the OS of gastric cancer patients, which reﬂected
that NLN should be deemed as an important predictor for the
prognosis of gastric cancer. In addition, the log odds of positive
lymph nodes (LODDS) was also proposed as new classiﬁcation of
metastatic lymph nodes recently.11 But there was still controversy
regarding contribution of the LODDS staging to the prognostic
prediction of gastric cancer.12e14 To date, there were no studies
comparing superiority of the above-mentioned four categories of
metastatic lymph nodes staging for the prognostic assessment in
gastric cancer.
In the light of above considerations, the aim of the current study
was to investigate which among N staging, RML staging, NLNd. All rights reserved.
Table 1
Clinicopathologic characteristics of 372 gastric cancer patients
following following radical gastrectomy plus extended
lymphadenectomy.
Factor Cases (%)
Sex
Male 240 (64.5)
Female 132 (35.5)
Age at surgery Mean  SD: 58.9  11.9 years
Range: 20e79 years
60 220 (59.1)
>60 152 (40.9)
Size of primary tumor Mean  SD: 5.3  2.7 cm
Range: 0.5e19 cm
5 227 (61.0)
>5 145 (39.0)
Location of primary tumor
Lower1/3 stomach 141 (37.9)
Middle1/3 stomach 73 (19.6)
Upper1/3 stomach 130 (34.9)
Whole stomach 28 (7.6)
Degree of differentiation
Well/Moderate 160 (43.0)
Poor 212 (57.0)
7th UICC/AJCC TNM classiﬁcation T staging
T1 16 (4.4)
T2 15 (4.0)
T3 21 (5.6)
T4 320 (86.0)
7th UICC/AJCC TNM classiﬁcation N staging
N0 117 (31.5)
N1 65 (17.5)
N2 82 (22.0)
N3 108 (29.0)
RML staging
RML1 117 (31.5)
RML2 59 (15.8)
RML3 108 (29.0)
RML4 88 (23.7)
NLN staging
NLN1 242 (65.1)
NLN2 74 (19.8)
NLN3 56 (15.1)
LODDS staging
LODDS1 100 (26.9)
LODDS2 64 (17.2)
LODDS3 71 (19.1)
LODDS4 137 (36.8)
Chemotherapy
Yes 29 (7.8)
No 343 (92.2)
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categorize the metastatic lymph nodes for predicting the OS in
gastric cancer patients.
2. Materials and methods
2.1. Patients
Between January 2001 and December 2006, the medical records of 1280 gastric
cancer patients who were diagnosed and had underwent surgery at the Department
of Gastrointestinal Oncology of Tianjin Cancer Hospital afﬁliated to Tianjin Medical
University, China were reviewed. Eligibility criteria for inclusion in this study were
as follows: 1) gastric adenocarcinoma identiﬁed by histo-pathological examination,
2) histologically conﬁrmed R0 resection, 3) availability of complete follow-up data,
4) radical resection and D2 lymphadenectomy performed, 5) patients whose num-
ber of lymph nodes retrieved were no less than 15. The exclusion criteria were: 1)
patients who underwent palliative surgery, 2) patients who had distant metastasis
or peritoneal dissemination that was conﬁrmed during the operation. Based on
these criteria, 908 patients out of 1280 were excluded from this study. Out of those
excluded 311 cases had less than 15 lymph nodes harvested for pathological ex-
amination, 102 cases had undergone a palliative gastrectomy, 237 cases had D0 and
D1 lymph node resection, 13 cases died within 1 month after surgery, 60 cases had
distant metastasis before the gastrectomy, 65 cases had peritoneal dissemination
before gastrectomy, and 120 cases were lost to follow-up. Finally 372 patients were
included for the analysis.
According to the 7th edition of the UICC/AJCC TNM staging system,4 based on the
number of tumor-inﬁltrated lymph nodes, the N stage was stratiﬁed into N0: no
positive, N1: 1e2 positive lymph node; N2: 3e6 positive lymph nodes; N3: >7
positive lymph nodes; RML was deﬁned as ratio between metastatic and examined
lymph nodes; NLN was calculated as the total lymph nodes minus positive lymph
nodes; LODDS was estimated by the log ðPLNþ 0:5Þ=ðNLNþ 0:5Þ, where PLN was
the number of positive lymph nodes and NLN was the number of negative lymph
nodes, 0.5 was added to both numerator and denomination to avoid singularity.13
2.2. Evaluated variables
With the log-rank analysis, we calculated the best cut-off values for continuous
data variables10 such as tumor size, RML, NLN, and LODDS. Clinical data collected for
subsequent analysis included sex (male or female), age at surgery (60 or >60), size
of primary tumor (5 cm or >5 cm), location of primary tumor (lower1/3 stomach,
middle1/3 stomach, upper1/3 stomach orWhole stomach), degree of differentiation
(well/moderate differentiated carcinoma or poor differentiated carcinoma), 7th
UICC/AJCC TNM classiﬁcation T staging (T1, T2, T3 or T4), 7th UICC/AJCC TNM clas-
siﬁcation N staging (N0, N1, N2 or N3), the RML staging (0 (RML1), 0e10% (RML2),
10.1e0.40% (RML3), >40% (RML4)), the NLN staging (>15 (NLN1),10e14 (NLN2) or
<9 (NLN3)), the LODDS stage (<1.5 (LODDS1), 1.5 to 1.0 (LODDS2), 1.0 to0.5
(LODDS3), >0.5 (LODDS4)), chemotherapy (yes or no).
2.3. Surgical treatment and adjuvant therapy
All patients were operated on according to the potentially radical gastrectomy
plus extended lymphadenectomy with pathologically negative resection margins.
The surgical procedure of reconstruction was chosen according to surgeon’s pref-
erence. Surgical specimens were evaluated by 7th UICC/AJCC TNM classiﬁcation for
gastric cancer. After surgery, 29 patients received the adjuvant chemotherapy based
on ﬂuorouracil and leucovorin calcium. Radiotherapy was not administrated to
patients routinely.
2.4. Statistical analysis
Categorical variables were statistically compared by c2 value or Fisher’s exact
test. Continuous data were shown as Mean SD, and were statistically compared by
using the ManneWhitney test. The KaplaneMeier method was used to estimate the
5-year survival rate (5-YSR), the log-rank test was used to determine signiﬁcance.
Factors that were deemed as of potential importance by the univariate analysis were
included in the multivariate analysis. Multivariate analysis was performed by the
Cox proportional hazards model, Hazard ratios (HR) and 95% CI were generated. To
ﬁnd the most appropriate categories of metastatic lymph nodes for gastric cancer,
we performed caseecontrol matched logistic regression analysis.15 First wematched
pairs of patients (the ratio between the number of cases and the number of
controls ¼ 1:1) in accordance with variables of sex, age, size of primary tumor,
location of primary tumor, degree of differentiation, 7th UICC/AJCC TNM classiﬁca-
tion T staging. Then, we performed multivariate survival analysis by means of casee
control matched logistic regression using the forward stepwise procedure for vari-
able selection. 5-YSR were compared with different N stages, NLN stages and LODDS
stages when stratiﬁed by RML stages and also with different RML stages when
stratiﬁed by N stages, NLN stages or LODDS stages. For all tests p value of <0.05 wasconsidered to be statistically signiﬁcant. The statistical analysis was performed using
the statistical analysis program package SPSS 17.0 (SPSS, Chicago, IL, USA).
2.5. Follow-up
After surgery, all the patients were followed every 6 months for 2 years, then
every year or until death. The median follow-up for the entire cohort was 52 (range
3e89) months. Ultrasound, computed tomographic scans, chest X-ray, and endos-
copy were performed at every visit.
3. Results
The TLN was within an average of 23.2  8.3 (Mean  SD)
examined nodes per case (median 21, range 15e66). The mean
number of metastatic nodes was within an average of 5.0  4.7
(Mean  SD) examined nodes per case (median 3, range 0e21) in
the overall series and with an average of 7.3  5.6 (Mean  SD)
examined nodes per case (median 6, range 1e21) in lymph nodes
positive patients. The clinicopathological characteristics of 372
gastric cancer patients after radical gastrectomy plus extended
lymphadenectomy are shown in Table 1.
Fig. 1. Survival curve for 372 gastric cancer patients following radical gastrectomy plus
extended lymphadenectomy according to 7th UICC/AJCC TNM classiﬁcation N staging.
Fig. 3. Survival curve for 372 gastric cancer patients following radical gastrectomy plus
extended lymphadenectomy according to NLN staging.
H. Liu et al. / International Journal of Surgery 11 (2013) 419e424 421
ORIGINAL RESEARCHThe 5-YSR of N0, N1, N2 and N3 patients were 77.8%, 49.2%,
25.6% and 4.6%, respectively (Fig. 1); The 5-YSR of RML1, RML2,
RML3 and RML4 were 77.8%, 49.2%, 24.1% and 3.4%, respectively
(Fig. 2); The 5-YSR of NLN1, NLN2 and NLN3 were 55.1%, 16.2% and
10.9%, respectively (Fig. 3); The 5-YSR of LODDS1, LODDS2, LODDS3
and LODDS4 patients were 77.0%, 57.8%, 29.6% and 9.5% respectively
(Fig. 4).
With univariate survival analysis, we found that the size of
primary tumor (p < 0.001), location of primary tumor (p < 0.001),
degree of differentiation (p < 0.001), 7th UICC/AJCC TNM classiﬁ-
cation T staging (p < 0.001), 7th UICC/AJCC TNM classiﬁcation N
staging (p < 0.001), RML staging (p < 0.001), NLN stagingFig. 2. Survival curve for 372 gastric cancer patients following radical gastrectomy plus
extended lymphadenectomy according to RML staging.(p < 0.001) and LODDS staging (p < 0.001) had signiﬁcant associ-
ation with the OS of gastric cancer; while sex, age and chemo-
therapy were not inﬂuential to the OS (p> 0.05). All of the potential
important factors identiﬁed in univariate analysis were included in
the multivariate analysis (Cox proportional hazards model). Degree
of differentiation (HR ¼ 1.404, 95% CI 1.068e1.848, p ¼ 0.015), 7th
UICC/AJCC TNM classiﬁcation T staging (HR ¼ 1.568, 95% CI 1.062e
2.314, p ¼ 0.024) and RML staging (HR ¼ 1.479, 95% CI 1.040e2.105,
p ¼ 0.030) were identiﬁed as the signiﬁcantly independent pre-
dictors of the OS of all patients (Table 2).
To obtain which was the most appropriate system for categori-
zation of metastatic lymph nodes for evaluating the OS of gastric
cancer, we adopted the caseecontrol matched logistic regressionFig. 4. Survival curve for 372 gastric cancer patients following radical gastrectomy plus
extended lymphadenectomy according to LODDS staging.
Table 2
Univariate and multivariate survival analysis results of 372 gastric cancer patients following radical gastrectomy plus extended lymphadenectomy.
Factor Univariate analysis Multivariate analysis
5-YSR c2 value p HR (95%CI) p
Sex 0.730 0.393 e e
Male 37.9
Female 43.2
Age at surgery (y) 0.947 0.331 e e
60 40.9
>60 38.8
Size of primary tumor (cm) 17.261 <0.001 e 0.750
5 48.5
>5 26.9
Location of primary tumor 27.180 <0.001 e 0.059
Lower1/3 stomach 53.2
Middle1/3 stomach 38.4
Upper1/3 stomach 31.5
Whole stomach 14.3
Degree of differentiation 19.678 <0.001 1.404 (1.068e1.847) 0.015
Well/moderate 53.1
Poor 30.2
7th UICC/AJCC TNM classiﬁcation T staging 40.075 <0.001 1.568 (1.062e2.314) 0.024
T1 81.3
T2 73.3
T3 71.4
T4 28.4
7th UICC/AJCC TNM classiﬁcation N staging 178.870 <0.001 e 0.078
N0 77.8
N1 49.2
N2 25.6
N3 4.6
RML staging 185.411 <0.001 1.470 (1.040e2.105) 0.030
RML1 77.8
RML2 49.2
RML3 24.1
RML4 3.4
NLN staging 129.581 <0.001 e 0.648
NLN1 55.1
NLN2 16.2
NLN3 10.9
LODDS staging 155.915 <0.001 e 0.970
LODDS1 77.0
LODDS2 57.8
LODDS3 29.6
LODDS4 9.5
Chemotherapy 0.598 0.439 e e
Yes 41.4
No 39.9
Bold values represents the p value < 0.05 was considered to be statistically signiﬁcant.
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compare the different staging system. In this caseecontrol matched
method, we matched 91 pairs of patients (the ratio between the
number of cases and the number of controls ¼ 1:1) in accordance
with variables of sex, age, size of primary tumor, location of primary
tumor, degree of differentiation, 7th UICC/AJCC TNM classiﬁcation T
staging. After performing caseecontrol matched logistic regression
analysis, we found that RML staging (p< 0.001, HR¼ 2.551) was the
most important indicator of the OS (Table 3).Table 3
Multivariate analysis showing the most appropriate category of metastatic lymph
nodes for evaluating the OS of gastric cancer by caseecontrol matched fashion.
Factor p value HR (95% CI)
The RML staging <0.001 2.551 (1.637e3.976)
7th UICC/AJCC TNM
classiﬁcation N staging
0.710 e
The NLN staging 0.206 e
The LODDS staging 0.963 e
Bold values represents the p value < 0.05 was considered to be statistically
signiﬁcant.For patients in each RML stage, the OS was homogenous be-
tween those in different N stages (pRML2¼ 0.387, pRML3¼ 0.062). For
patients in N2 stage and N3 stage, statistical differences in the OS
could be observed among patients in different RML stages
(pN2 ¼ 0.035, pN3 ¼ 0.047). For patients in RML3 and RML4 stage,
the OS was highly homogenous (pRML3 ¼ 0.628, pRML4 ¼ 0.199), for
patients in NLN1 stage and NLN2 stage. Signiﬁcant differences in
the OS could be observed among patients in different RML stages
(pNLN1 < 0.001, pNLN2 ¼ 0.009). For patients in each RML stage, the
OS was highly homogenous between those in different LODDS
stages (pRML1 ¼ 0.888, pRML2 ¼ 0.626, pRML3 ¼ 0.197), for patients in
LODDS2 stage and LODDS4 stage, statistical differences in the OS
could be observed among patients in different RML stages
(pLODDS2 ¼ 0.023, pLODDS4 < 0.001) (Table 4).4. Discussion
More than 50% of gastric cancer patients were accompanied by
lymph node metastases at initial diagnosis, which led to the dismal
prognosis.16,17 Precise categorization of metastatic lymph nodes
conveyed the extent of disease, and impacted signiﬁcant on further
Table 4
Overall survival with different N stage, NLN stage and LODDS stage stratiﬁed by the RML stages.
RML1 RML2 RML3 RML4 pa
No 5-YSR No 5-YSR No 5-YSR No 5-YSR
N staging
N0 117 74.1 e e e e e e e
N1 e e 54 48.1 11 54.4 e e 0.520
N2 e e 5 60.0 77 23.4 e e 0.035
N3 e e e e 20 10.0 88 3.4 0.047
pb e 0.387 0.062 e
NLN staging
NLN1 117 74.1 58 50.0 65 23.1 2 0 0.000
NLN2 e e 1 0 43 25.6 30 13.3 0.009
NLN3 e e e e e e 56 3.6 e
pc e <0.001 0.628 0.199
LODDS staging
LODDS1 99 76.8 1 100.0 e e e e 0.570
LODDS2 18 83.3 46 47.8 e e e e 0.023
LODDS3 e e 12 50.0 59 27.1 e e 0.101
LODDS4 e e e e 49 20.4 88 3.4 0.001
pd 0.888 0.626 0.197 e
pa: Comparison of the overall survival between different RML stages.
pb: Comparison of the overall survival between different N stages.
pc: Comparison of the overall survival between different NLN stages.
pd: Comparison of the overall survival between different LODDS stages.
Bold values represents the p value < 0.05 was considered to be statistically signiﬁcant.
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edition of guidelines for evaluating the status of lymph nodes,
which had been validated to be more accurate than the previous
versions of the N staging in predicting the OS in gastric patients.18
But N staging still had some deﬁciencies. The primary ﬂaw of N
staging was that accuracy of predicting the prognosis was signiﬁ-
cantly inﬂuenced by the number of the total lymph nodes (TLN)
retrieved. The N staging being inﬂuenced by the TNL, called as the
phenomenon of Will Rogers, which could not be avoided if the
retrieved TLN were small.19 According to the Japanese gastric can-
cer treatment guidelines,20 only when the number of the retrieved
lymph nodes was not less than 15, it could be regarded as an
adequate lymphadenectomy for accurate staging. Unfortunately
compliance with the guidelines was rather poor, with only an
average of 10 lymph nodes being assessed and only 29% of patients
having more than 15 lymph nodes evaluated in the United States.12
RML was proposed to avoid the migration of N staging. Many
studies demonstrated that RML staging was an independent
prognostic factor in the prognosis of gastric cancer and could pre-
dict prognosis more precisely than N staging.5e7,21 Also some in-
vestigators demonstrated that tumor-ratio-metastasis (TRM)
system which based on the RML staging was superior to TNM
system in the prediction of prognosis.22 Yet some authors argued
that RML staging might not be suitable for evaluating the patients
with negative lymph nodes in gastric cancer because there was no
difference in prognostic value among RML staging and N staging for
the patients with negative lymph node.12 Also some studies found
with different numbers of retrieved lymph nodes, patients in the
same RML stage had different prognosis.11 And the best cut-off of
RML staging was in debate. These defects might inhibit the RML
staging to develop as an alternative to the current N staging.
Recently, the negative lymph nodes (NLN) were proposed as a
new system of classiﬁcation for metastatic lymph nodes for pre-
diction of the OS in gastric cancer patients. After analyzing the
clinicopathological data of 634 gastric cancer patients who un-
derwent distal gastrectomy, Huang et al.23 conﬁrmed that
increasing the negative lymph node counts could improve the OS of
gastric cancer patients. Deng et al.10,24 demonstrated that the har-
vesting enough of negative lymph nodes was the most important
factor in improving the OS of gastric cancer patients withperigastric node metastasis after surgery. They also found the NLN
could inﬂuence the prognostic prediction of gastric cancer patients.
They recommended NLN should be regarded as a new category of
the nodal metastasis in evaluating the prognosis of gastric cancer
patients.
LODDS, another novel indicator for evaluating the status of
lymph nodes, provided a new chance to improve the accuracy of N
stage for prognostic assessment. There were different viewpoints
on the value of LODDS staging in prognostic assessment. Wang
et al.11 concluded that the LODDS stage had a better prognostic
value than RML stage in colorectal cancer, while Song et al.25
thought the RML staging was more suitable than N staging and
LODDS staging in prognostic assessment as complicated calculation
procedure of LODDSmight be not suitable for clinical application. In
case of breast cancer, Vinh-Hung et al.26 draw the conclusion that
the LODDS staging was inferior to the RML staging in patients with
positive lymph nodes. For gastric cancer, some authors12,13 found
that the LODDS staging was more reliable than N staging and RML
staging in prognostic assessment, Yu C et al.14 found the LODDS
staging might reﬂect a false outcome for patients of gastric cancer
with adopting the method of HR of each category of metastatic
lymph nodes.
In this study, we demonstrated the RML staging was superior to
the LODDS staging, NLN staging or N staging in the prediction of the
OS of 372 gastric cancer patients. The following reasons were taken
into account: Firstly, although the N staging, RML staging, NLN
staging and LODDS staging were all identiﬁed as the signiﬁcant
prognostic factors in univariate analysis, but in Cox proportional
hazards model, only the RML staging system was identiﬁed as the
independent prognostic factor among the four categories of met-
astatic lymph nodes. Secondly, we adopted caseecontrol matched
logistic regression to directly compare the four categories of met-
astatic lymph nodes. After analyzing the matched couples, we also
demonstrated that the RML staging was the best indictor of the OS.
Thirdly, in another analysis where the OS was compared among
different N stages, NLN stages and LODDS stages while being
stratiﬁed by RML stages and also with different RML stages when
stratiﬁed by N stages, NLN stages or LODDS stages, we found the
RML staging had the best prognostic homogeneity than LODDS
staging, NLN staging or N staging. Ueno et al.27 recommended that
H. Liu et al. / International Journal of Surgery 11 (2013) 419e424424
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better staging system.
Although our study was a retrospective small-scale investiga-
tion, we demonstrated that among four system of categorization of
metastatic lymph nodes for gastric cancer patients after surgery,
the RML staging could predict the OS more adequately and pre-
cisely than LODDS staging, NLN staging or N staging.
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